High‐Affinity Dimeric Aptamers Enable the Rapid Electrochemical Detection of Wild‐Type and B.1.1.7 SARS‐CoV‐2 in Unprocessed Saliva

Angewandte Chemie - International Edition - Tập 60 Số 45 - Trang 24266-24274 - 2021
Zijie Zhang1,2, Richa Pandey3,2, Jiuxing Li1,2, Jimmy Gu1, Dawn White4, Hannah D. Stacey1,5,6, Jann C. Ang1,5,6, Catherine‐Jean Steinberg7, Alfredo Capretta4,6, Carlos D. M. Filipe8, Karen L. Mossman7,6, Cynthia Balion9, Matthew S. Miller1,5,6, Bruno J. Salena7, Deborah Yamamura9,6, Leyla Soleymani3,10, John D. Brennan4, Yingfu Li4,1,6,10
1Department of Biochemistry and Biomedical Sciences, McMaster University, Canada
2these authors contributed equally to this work
3Department of Engineering Physics, McMaster University, Canada
4Biointerfaces Institute, McMaster University, Canada
5McMaster Immunology Research Centre, McMaster University, Canada
6Michael G. DeGroote Institute of Infectious Disease Research, McMaster University, Canada
7Department of Medicine, McMaster University, Canada
8Department of Chemical Engineering, McMaster University, Canada
9Department of Pathology and Molecular Medicine, McMaster University, Canada
10School of Biomedical Engineering, McMaster University, 1280 Main Street West, Hamilton, Ontario, L8S 4K1 Canada

Tóm tắt

Abstract

We report a simple and rapid saliva‐based SARS‐CoV‐2 antigen test that utilizes a newly developed dimeric DNA aptamer, denoted as DSA1N5, that specifically recognizes the spike proteins of the wildtype virus and its Alpha and Delta variants with dissociation constants of 120, 290 and 480 pM, respectively, and binds pseudotyped lentiviruses expressing the wildtype and alpha trimeric spike proteins with affinity constants of 2.1 pM and 2.3 pM, respectively. To develop a highly sensitive test, DSA1N5 was immobilized onto gold electrodes to produce an electrochemical impedance sensor, which was capable of detecting 1000 viral particles per mL in 1:1 diluted saliva in under 10 min without any further sample processing. Evaluation of 36 positive and 37 negative patient saliva samples produced a clinical sensitivity of 80.5 % and specificity of 100 % and the sensor could detect the wildtype virus as well as the Alpha and Delta variants in the patient samples, which is the first reported rapid test that can detect any emerging variant of SARS‐CoV‐2.

Từ khóa


Tài liệu tham khảo

10.1126/science.abe9187

Dinnes J., 2021, Cochrane Database Syst. Rev., 3

10.1021/acssensors.0c01377

10.1128/JCM.01136-20

O. L. Akingba K. Sprong D. R. Hardie medRxiv2021 2021.02.03.21251057.

10.1016/j.eclinm.2020.100677

10.1016/j.jinf.2021.02.014

10.1016/j.jcv.2020.104659

10.1007/s10096-021-04202-9

10.1016/j.jinf.2020.12.007

10.1503/cmaj.210100

10.1021/acs.analchem.0c03202

10.3389/fcimb.2021.632646

10.1038/s41551-020-00655-z

10.1021/acs.analchem.0c05059

10.1021/acssensors.0c01984

10.1016/j.bios.2020.112715

10.1038/s41467-021-21121-7

10.1016/j.matt.2020.09.027

10.1021/jacs.0c10810

10.1039/D1AY00041A

10.1016/j.bios.2020.112686

10.1016/j.bios.2020.112437

10.1021/acsnano.0c02823

S. Mahari A. Roberts D. Shahdeo S. Gandhi bioRxiv2020 2020.04.24.059204.

10.1016/j.jcv.2021.104785

10.3390/s21020390

10.1016/j.bios.2021.113111

10.1038/s41587-020-0513-4

10.1080/22221751.2020.1729069

10.1038/s41467-020-19231-9

10.1016/j.jbc.2021.100346

10.1021/acs.analchem.0c01394

10.1002/anie.202100225

10.1002/ange.202100225

10.1002/anie.202100316

10.1002/ange.202100316

10.1002/anie.202100345

10.1002/ange.202100345

10.1039/D0SC03920A

10.1093/nar/gkab574

10.1021/jacs.1c02929

10.1016/j.chembiol.2008.07.004

10.1172/JCI33365

10.3390/molecules22101770

10.1021/jacs.7b04547

10.1002/cbic.201900265

10.3390/molecules25225227

10.1016/j.mcp.2020.101636

10.1021/acsami.0c15644

10.1038/s41586-020-2665-2

10.1016/j.cell.2020.09.018

10.1039/c2lc41127j

10.1002/celc.201800848

10.1021/ja056555h

10.1021/ja067024b

10.1038/nchem.1092

10.1016/j.snb.2005.06.017

10.1149/1945-7111/ab69fd

F. Tian B. Tong L. Sun S. Shi B. Zheng Z. Wang X. Dong P. Zheng bioRxiv2021 2021.02.14.431117.

10.2807/1560-7917.ES.2021.26.24.2100509

10.1016/S0140-6736(21)01290-3

10.7554/eLife.57309

10.1128/JVI.00645-06

10.3390/v12050513

10.1038/s41423-020-0426-7

10.1038/s41467-020-15562-9

10.1016/j.bios.2020.112905

“COVID-19 antigen testing devices: Notice on minimum value for sensitivity ” can be found underhttps://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/medical-devices/testing/antigen.html.

10.1093/clinchem/39.4.561

“Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency (Revised) ” can be found underhttps://www.fda.gov/regulatory-information/search-fda-guidance-documents/policy-coronavirus-disease-2019-tests-during-public-health-emergency-revised.

“Emergency Use Authorization of Medical Products and Related Authorities ” can be found underhttps://www.fda.gov/regulatory-information/search-fda-guidance-documents/emergency-use-authorization-medical-products-and-related-authorities.

10.1126/science.abd7728

10.1126/sciimmunol.abe5511

“Human Salivary Proteome Wiki ” can be found underhttps://salivaryproteome.nidcr.nih.gov/public/index.php/Main Page.

10.1016/j.jbiotec.2020.12.018

10.1038/s41587-020-0659-0

10.1056/NEJMc2016359